Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Black

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cell Reports Methods|July 11, 2025
Deuterium labeling enables proteome-wide turnover kinetics analysis in cell cultureLorena Alamillo, Dominic C M Ng, Jordan Currie, et al.
The American Journal of Cardiology|December 20, 2011
Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary interventionWilliam Chan, Dion Stub, David J Clark, et al.
International Journal of Cardiology|May 7, 2013
Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registryThathya V Ariyaratne, Zanfina Ademi, Stephen J Duffy, et al.
The Medical Journal of Australia|October 4, 2006
Use of drug-eluting stents in Victorian public hospitalsBryan P Yan, Andrew E Ajani, Stephen J Duffy, et al.
Cardiovascular Therapeutics|January 8, 2014
Cardiovascular medication use following percutaneous coronary intervention: the Australian experienceJustin A Cole, Angela L Brennan, Andrew E Ajani, et al.
The Medical Journal of Australia|October 22, 2008
Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registryAndrew E Ajani, Christopher M Reid, Stephen J Duffy, et al.
American Heart Journal|April 21, 2009
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stentsMichelle J Butler, David Eccleston, David J Clark, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shockHan S Lim, Omar Farouque, Nick Andrianopoulos, et al.
International Journal of Cardiology|December 3, 2011
Survival in patients with myocardial infarction complicated by out-of-hospital cardiac arrest undergoing emergency percutaneous coronary interventionHan S Lim, Dion Stub, Andrew E Ajani, et al.
Journal of Cancer Research and Clinical Oncology|January 21, 2014
Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancerEdward B Garon, Heather R Christofk, Wylie Hosmer, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cell Reports Methods|July 11, 2025
Deuterium labeling enables proteome-wide turnover kinetics analysis in cell cultureLorena Alamillo, Dominic C M Ng, Jordan Currie, et al.
The American Journal of Cardiology|December 20, 2011
Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary interventionWilliam Chan, Dion Stub, David J Clark, et al.
International Journal of Cardiology|May 7, 2013
Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registryThathya V Ariyaratne, Zanfina Ademi, Stephen J Duffy, et al.
The Medical Journal of Australia|October 4, 2006
Use of drug-eluting stents in Victorian public hospitalsBryan P Yan, Andrew E Ajani, Stephen J Duffy, et al.
Cardiovascular Therapeutics|January 8, 2014
Cardiovascular medication use following percutaneous coronary intervention: the Australian experienceJustin A Cole, Angela L Brennan, Andrew E Ajani, et al.
The Medical Journal of Australia|October 22, 2008
Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registryAndrew E Ajani, Christopher M Reid, Stephen J Duffy, et al.
American Heart Journal|April 21, 2009
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stentsMichelle J Butler, David Eccleston, David J Clark, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shockHan S Lim, Omar Farouque, Nick Andrianopoulos, et al.
International Journal of Cardiology|December 3, 2011
Survival in patients with myocardial infarction complicated by out-of-hospital cardiac arrest undergoing emergency percutaneous coronary interventionHan S Lim, Dion Stub, Andrew E Ajani, et al.
Journal of Cancer Research and Clinical Oncology|January 21, 2014
Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancerEdward B Garon, Heather R Christofk, Wylie Hosmer, et al.
Pageof 4